Qualitätssicherungsstudie zum Magenkarzinom in Deutschland

Böttcher K, Roder JD, Busch R et al. (1993) Epidemiologie des Magenkarzinoms aus chirurgischer Sicht. Dtsch Med Wochenschr 118: 729–736

Böttcher K, Siewert JR, Roder JD et al. (1994) Risiko der chirurgischen Therapie des Magenkarzinoms in Deutschland. Ergebnisse der Deutschen Magencarcinom-Studie 1992. Chirurg 65: 298–306

Cunningham D, Allum WH, Stenning SP et al. MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11–20

Gastinger I, Koch A, Marusch F et al. (2002) Die Bedeutung prospektiver multizentrischer Beobachtungsstudien für den Erkenntnisgewinn in der Chirurgie. Chirurg 73: 161–166

Hansson LE, Ekstrom AM, Bergstrom R, Nyren O (2000) Surgery for stomach cancer in a defined Swedish population: current practices and operative results. Swedish Gastric Cancer Study Group. Eur J Surg 166: 787–795

MacDonald JS, Smalley SR, Benedetti J et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adencarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725–730

Markus B, Pinter G (2001) Partial versus total gastrectomy in the surgical treatment of stomach cancer. Magy Seb 54: 361–367

Meyer C, Lozac’h P, Rohr S et al. French Association of Surgery (2002) Gastric cancer: the French survey. Acta Gastroenterol Belg 65: 161–165

Meyer L, Meyer F, Dralle H et al. (2005) Insufficiency risk of esophagojejunal anstomosis after total abdominal gastrectomy for gastric carcinoma. Langenbecks Arch Surg 390: 510–516

Meyer L, Steinert R, Nowak L et al. (2005) Prospektive Multizenterstudie zur Chirurgie des Magenkarzinoms – Ein Beitrag zur Klinischen Versorgungsforschung. Zentralbl Chir 130: 97–103

Ott K, Fink U, Becker K et al. (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21: 4604–4610

Sendler A, Etter M, Böttcher K, Siewert JR (2002) Resektionsausmaß in der Chirurgie des Magenkarzinoms. Chirurg 73: 316–324

Seulin P, Carrere N, Bloom E et al. (2000) Stomach cancer: have changes in surgical strategy influenced the results? 20-year retrospective study. Ann Chir 125: 131–136

Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449–461

Uhl W, Wente MN, Büchler MW (2000) Surgical clinical studies and their practical realization. Chirurg 71: 615–625

www.zvfk.de-content-e89-e441-e444-memorandumzurVersorgungsforschung1.3.pdf

www.zvfk.de-content-e89-e441-e857-MemorandumII.pdf

Ychou M, Pignon JP, Lasser P et al. (2006) Phase III preliminary results of preoperative fluorouracil (F) and cisplatin (P) versus surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC 94012-FFCD 9703 trial. #4026 ASCO 2006